Bayer AG (OTCMKTS:BAYRY) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $15.64 and traded as low as $15.35. Bayer shares last traded at $15.41, with a volume of 100,247 shares.
BAYRY has been the topic of a number of recent analyst reports. Deutsche Bank cut shares of Bayer from a “buy” rating to a “hold” rating in a report on Sunday, March 31st. Bryan, Garnier & Co cut shares of Bayer from a “neutral” rating to a “sell” rating in a report on Thursday, March 28th. Berenberg Bank initiated coverage on shares of Bayer in a report on Monday, April 1st. They set a “hold” rating on the stock. ValuEngine cut shares of Bayer from a “sell” rating to a “strong sell” rating in a report on Monday, April 1st. Finally, Bank of America reiterated a “neutral” rating on shares of Bayer in a report on Monday, March 25th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. Bayer presently has an average rating of “Hold”.
The company has a current ratio of 1.59, a quick ratio of 1.04 and a debt-to-equity ratio of 0.80. The firm has a market cap of $57.67 billion, a P/E ratio of 8.83, a P/E/G ratio of 0.73 and a beta of 0.99.
About Bayer (OTCMKTS:BAYRY)
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.
Featured Article: What is net income?
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.